Intercure Ltd. Logo

Intercure Ltd.

Produces and distributes GMP-certified, pharmaceutical-grade medical cannabis products.

INCR | TA

Overview

Corporate Details

ISIN(s):
IL0011063760
LEI:
549300KI5ESXF8F5GP06
Country:
Israel
Address:
11 USSISHKIN STREET, 3844346 HADERA

Description

Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-08-15 18:21
Second Quarter 2022 and Recent Financial & Operating Highlights
English 35.8 KB
2022-08-12 19:20
ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 15, 2022
English 313.5 KB
2022-08-12 19:20
ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 15, 2022
English 1001.2 KB
2022-08-12 19:20
ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 15, 2022
English 143.2 KB
2022-08-11 19:41
InterCure to Release its Q2 2022 Results and Hold a Conference Call on August 1…
English 172.2 KB
2022-08-11 19:41
InterCure to Release its Q2 2022 Results and Hold a Conference Call on August 1…
English 35.9 KB
2022-07-21 18:39
InterCure Reports Record Preliminary 2022 Second Quarter Revenue; file its full…
English 179.3 KB
2022-07-21 18:39
InterCure Reports Record Preliminary 2022 Second Quarter Revenue; file its full…
English 35.8 KB
2022-07-15 20:17
Pursuant to a request from the above-mentioned reporting issuer, we wish to adv…
English 44.2 KB
2022-07-15 20:17
Pursuant to a request from the above-mentioned reporting issuer, we wish to adv…
English 35.8 KB
2022-06-21 18:05
InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria
English 136.4 KB
2022-06-21 18:05
InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria
English 35.8 KB
2022-06-02 17:38
Announced opening of its flagship Cookies pharmacy in Be'er Sheva
English 317.7 KB
2022-06-02 17:38
Announced opening of its flagship Cookies pharmacy in Be'er Sheva
English 35.8 KB
2022-05-17 02:44
Financial results for the first quarter of 2022
English 344.1 KB

Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Intercure Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Intercure Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.